INSTITUT CLAUDIUS REGAUD
Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival
- Conditions
- Metastatic Breast Cancer Starting a Third Line Chemotherapy
- First Posted Date
- 2012-04-10
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 267
- Registration Number
- NCT01574170
- Locations
- 🇫🇷
Institut de Cancérologie de l'Ouest Paul Papin, Angers, France
🇫🇷C.M.C.O. Claude Bernard, Albi, France
🇫🇷CHU Jean Minjoz, Besançon, France
Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2012-03-14
- Last Posted Date
- 2013-06-04
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 29
- Registration Number
- NCT01553903
- Locations
- 🇫🇷
Institut Claudius REGAUD, Toulouse, France
Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
- Conditions
- Glioblastoma
- Interventions
- Radiation: RadiotherapyRadiation: Experimental arm
- First Posted Date
- 2012-01-11
- Last Posted Date
- 2021-01-12
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 180
- Registration Number
- NCT01507506
- Locations
- 🇫🇷
Centre Paul Strauss, Strasbourg, France
🇫🇷Centre Leon Berard, Lyon, France
🇫🇷Clinique Claude Bernard, Albi, France
Pharmacology of Adjuvant Hormonotherapy in Breast Cancer
- Conditions
- Hormono-depending Adjuvant Breast Cancer
- Interventions
- Drug: Tamoxifen, Letrozole, Anastrozole or Exemestane
- First Posted Date
- 2010-05-20
- Last Posted Date
- 2018-03-02
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 2000
- Registration Number
- NCT01127295
- Locations
- 🇫🇷
CHU de Bordeaux, Bordeaux, France
🇫🇷Centre Hospitalier d'Auch, Auch, France
🇫🇷Clinique Claude Bernard, Albi, France
Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer
- Conditions
- Locally Advanced Non Small Cell Lung Cancer (NSCLC)
- Interventions
- Drug: cilengitide, radiochemotherapy
- First Posted Date
- 2010-05-07
- Last Posted Date
- 2022-05-24
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 14
- Registration Number
- NCT01118676
- Locations
- 🇫🇷
CHU Toulouse Larrey, Toulouse, France
🇫🇷Institut Claudius Regaud, Toulouse, France
Adipose Tissue Transfer for Moderate Breast Cancer Conservative Treatment Sequella
- Conditions
- Breast Cancer
- Interventions
- Procedure: fatty tissue transfer
- First Posted Date
- 2009-12-18
- Last Posted Date
- 2018-08-22
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 196
- Registration Number
- NCT01035268
- Locations
- 🇫🇷
INSTITUT DE CANCEROLOGIE DE L'OUEST - Centre René Gauducheau, Saint-Herblain, France
🇫🇷Centre Henri Becquerel, Rouen, France
🇫🇷CHU Rangueil, Toulouse, France
Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant
- Conditions
- Breast Neoplasms
- First Posted Date
- 2009-06-12
- Last Posted Date
- 2009-06-12
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 15
- Registration Number
- NCT00919399
- Locations
- 🇫🇷
CHU de Toulouse Rangueil, Toulouse, France
🇫🇷Institut Claudius Regaud, Toulouse, France
Observation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members Sarcoma
- Conditions
- Soft Tissue Sarcoma of Members
- Interventions
- Other: absence of radiotherapyRadiation: Radiotherapy
- First Posted Date
- 2009-03-27
- Last Posted Date
- 2018-08-22
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 77
- Registration Number
- NCT00870701
- Locations
- 🇫🇷
Institut de Cancerologie de La Loire, Saint-Priest en Jarez, France
🇫🇷Centre Paul Strauss, Strasbourg, France
🇫🇷Institut Bergonié, Bordeaux, France
Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis
- Conditions
- Germ Cell Tumors
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2021-01-12
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 101
- Registration Number
- NCT00864318
- Locations
- 🇫🇷
Hopital St André, Bordeaux, France
🇫🇷Centre Léon Bérard, Lyon, France
🇫🇷Institut Claudius Regaud, Toulouse, France
Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain
- First Posted Date
- 2008-12-23
- Last Posted Date
- 2014-11-05
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 21
- Registration Number
- NCT00814021
- Locations
- 🇫🇷
Institut Claudius Regaud, Toulouse, France